Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PLAU | P00749 | 2/20 | 0.45 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.45 |
| ▸ | F12 | P00748 | 1/20 | 0.45 |
| ▸ | NCF1 | P14598 | 1/20 | 0.45 |
| ▸ | NOS3 | P29474 | 1/20 | 0.45 |
| ▸ | NOS1 | P29475 | 1/20 | 0.45 |
| ▸ | NOS2 | P35228 | 1/20 | 0.45 |
| ▸ | BACE1 | P56817 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | CCR1 | P32246 | 4/20 | 0.42 |
| ▸ | CCR8 | P51685 | 4/20 | 0.42 |
| ▸ | LMNA | P02545 | 3/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | MMP2 | P08253 | 2/20 | 0.42 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | TP53 | P04637 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29475320 | 0.96 | CYP1A2 (0.44) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL30022648 | 0.96 | CYP1A2 (0.44) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL5471458 | 0.96 | CYP1A2 (0.44) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL30421514 | 0.94 | CYP1A2 (0.43) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL9999520 | 0.92 | CYP1A2 (0.41) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL32665271 | 0.91 | CYP1A2 (0.48) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL5478954 | 0.91 | CYP1A2 (0.48) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL9999522 | 0.82 | CYP1A2 (0.47) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL12746470 | 0.81 | APP (0.33) | PLAUCYP2A6F12NCF1NOS3 | |
| SCHEMBL21803649 | 0.78 | PSMD14 (0.42) | CYP2A6CCR1CCR8ALDH1A1CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101176217-B | Azaperylenes as organic semiconductors | CIBA SC HOLDING AG | 2013-07-17 | — | — | CN | disclosed |
| EP-1880428-B1 | AZAPERYLENES AS ORGANIC SEMICONDUCTORS | BASF SE (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-7723521-B2 | Azaperylenes as organic semiconductors | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 2010-05-25 | — | — | US | disclosed |
| US-20090101890-A1 | Azaperylenes as organic semiconductors | CIBA SPECIALTY CHEMICALS CORP. | 2009-04-23 | — | — | US | disclosed |
| CN-101176217-A | Azaperylenes as organic semiconductors | CIBA SC HOLDING AG (CH) | 2008-05-07 | — | — | CN | disclosed |
| EP-1880428-A1 | AZAPERYLENES AS ORGANIC SEMICONDUCTORS | CIBA SPECIALTY CHEMICALS HOLDING INC. Patent Departement (CH) | 2008-01-23 | — | — | EP | disclosed |
| US-7183010-B2 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK CORPORATION (US) | 2007-02-27 | — | — | US | disclosed |
| WO-2006120143-A1 | AZAPERYLENES AS ORGANIC SEMICONDUCTORS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2006-11-16 | — | — | WO | disclosed |
| US-20040076853-A1 | Organic light-emitting diode devices with improved operational stability | EASTMAN KODAK COMPANY | 2004-04-22 | — | — | US | disclosed |
| JP-2000231987-A | ORGANIC ELECTROLUMINESCENT ELEMENT AND DISPLAY DEVICE USING IT | FUJITSU LTD | 2000-08-22 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090101890-A1 | Azaperylenes as organic semiconductors | RPS7, RPS8, ORC3 | PLAU 4859/4885CYP2A6 2066/4885F12 1322/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.